Vitrolife 관리

관리 기준 확인 2/4

Vitrolife CEO는 Bronwyn Brophy O´Connor, Aug2023 에 임명되었습니다 의 임기는 1.25 년입니다. 총 연간 보상은 SEK 7.44M, 74.5% 로 구성됩니다. 74.5% 급여 및 25.5% 보너스(회사 주식 및 옵션 포함). 는 SEK 4.28M 가치에 해당하는 회사 주식의 0.014% 직접 소유합니다. 4.28M. 경영진과 이사회의 평균 재임 기간은 각각 1.3 년과 6.8 년입니다.

주요 정보

Bronwyn Brophy O´Connor

최고 경영자

SEK 7.4m

총 보상

CEO 급여 비율	74.5%
CEO 임기	1.3yrs
CEO 소유권	0.01%
경영진 평균 재임 기간	1.3yrs
이사회 평균 재임 기간	6.8yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Bronwyn Brophy O´Connor 의 보수는 Vitrolife 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	-SEK 4b
Jun 30 2024	n/a	n/a	-SEK 4b
Mar 31 2024	n/a	n/a	-SEK 4b
Dec 31 2023	SEK 7m	SEK 6m	-SEK 4b

보상 대 시장: Bronwyn 의 총 보상 ($USD 673.62K ) UK 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 2.68M ).

보상과 수익: Bronwyn 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Bronwyn Brophy O´Connor (50 yo)

1.3yrs

테뉴어

SEK 7,439,000

보상

Ms. Bronwyn Brophy O´Connor is President and Chief Executive Officer at Vitrolife AB (publ) since joining from August 01, 2023. She has an impressive track record as a leader of global Life science and Med...

리더십 팀

이름	위치	테뉴어	보상	소유권
Bronwyn Brophy O´Connor	CEO & President	1.3yrs	SEK 7.44m	0.014% SEK 4.3m
Patrik Tolf	Chief Financial Officer	2.8yrs	데이터 없음	0.0096% SEK 2.9m
Claus Bisgaard	Senior Vice President of Technologies	no data	데이터 없음	0.00028% SEK 83.9k
Guillermo Ferrando	Vice President Strategy & Corporate development	1.8yrs	데이터 없음	데이터 없음
Olivia Natens	Senior Vice President of Sales & Marketing	less than a year	데이터 없음	데이터 없음
Frank Pettersson	Acting Senior Vice President of HR & Sustainability	1.1yrs	데이터 없음	0.0013% SEK 392.7k
Rickard Ericsson	Senior Vice President of Consumables	less than a year	데이터 없음	0.0061% SEK 1.8m
Ricardo Capella	Senior Vice President Genetic Services	2.8yrs	데이터 없음	0.0044% SEK 1.3m

1.3yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 관리: 0YAY 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Henrik Blomquist	Director	5.5yrs	SEK 883.00k	0.0081% SEK 2.4m
Jon Sigurdsson	Chairman of the Board	9.8yrs	SEK 16.30m	0.022% SEK 6.7m
Lars Holmqvist	Independent Director	6.8yrs	SEK 450.00k	데이터 없음
Pia Marions	Independent Director	11.6yrs	SEK 500.00k	0.0037% SEK 1.1m
Karen Soerensen	Independent Director	4.4yrs	SEK 500.00k	데이터 없음

6.8yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: 0YAY 의 이사회는 경험(평균 재직 기간 6.8 년)으로 간주됩니다.

Vitrolife 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Vitrolife AB (Publ) Announces Election Committee Appointments

Director recently bought kr1.6m worth of stock

Vitrolife AB (publ) Announces Election Committee Appointments

Vitrolife AB (publ) Announces Resignation of Maria Forss as Senior Vice President

Insufficient new directors

Vitrolife AB Announces Board Changes

Recent updates

Vitrolife AB (publ) to Report Fiscal Year 2024 Final Results on Mar 27, 2025

Vitrolife AB (publ) to Report Q4, 2025 Results on Jan 29, 2026

Third quarter 2024 earnings released: EPS: kr0.86 (vs kr0.90 in 3Q 2023)

Vitrolife AB (Publ) Announces Election Committee Appointments

Now 23% overvalued after recent price rise

Now 21% overvalued after recent price rise

Vitrolife AB (publ) to Report Q3, 2025 Results on Oct 29, 2025

Second quarter 2024 earnings released: EPS: kr1.06 (vs kr0.78 in 2Q 2023)

Vitrolife AB (publ) (OM:VITR) acquired Stb Zorg B.V.

Director recently bought kr1.6m worth of stock

Vitrolife AB (publ) (OM:VITR) signed an agreement to acquire Stb Zorg B.V. for €18 million.

Vitrolife AB (Publ) Approves Dividend for the Financial Year 2023

Upcoming dividend of kr1.00 per share

Now 20% undervalued

First quarter 2024 earnings released: EPS: kr0.85 (vs kr0.74 in 1Q 2023)

Dividend increased to kr1.00

Full year 2023 earnings released: kr28.44 loss per share (vs kr2.91 profit in FY 2022)

Vitrolife AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Vitrolife AB (Publ) Reports Non-Cash Impairment for the Fourth Quarter of 2023

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: EPS: kr0.90 (vs kr0.80 in 3Q 2022)

Vitrolife AB (publ) Announces Election Committee Appointments

Vitrolife AB (publ) Announces Resignation of Maria Forss as Senior Vice President

Insufficient new directors

Vitrolife AB Announces Board Changes

Chief Financial Officer recently bought kr335k worth of stock

Investor sentiment deteriorates as stock falls 21%

New minor risk - Share price stability

Second quarter 2023 earnings released: EPS: kr0.78 (vs kr0.96 in 2Q 2022)

Vitrolife AB (publ) to Report Q3, 2024 Results on Oct 24, 2024

Chief Financial Officer recently bought kr535k worth of stock

Upcoming dividend of kr0.85 per share at 0.4% yield

Full year 2022 earnings released: EPS: kr2.91 (vs kr2.98 in FY 2021)

Full year 2022 earnings released: EPS: kr2.91 (vs kr2.98 in FY 2021)

Vitrolife AB (publ) Proposes Dividend for 2022

Vitrolife AB (publ) Announces Executive Changes

Second quarter 2022 earnings released: EPS: kr0.96 (vs kr0.79 in 2Q 2021)

Investor sentiment improved over the past week

Vitrolife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

Vitrolife AB (publ) Announces Election Committee Appointments

Now 29% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Vitrolife AB (Publ) Announces Retirement of Thomas Axelsson as CEO

Second quarter 2022 earnings released: EPS: kr0.96 (vs kr0.79 in 2Q 2021)

Vitrolife AB (publ), Annual General Meeting, Apr 27, 2023

Chief Financial Officer recently bought kr496k worth of stock

First quarter 2022 earnings released: EPS: kr0.61 (vs kr1.09 in 1Q 2021)

First quarter 2022 earnings released: EPS: kr0.61 (vs kr1.09 in 1Q 2021)

Upcoming dividend of kr0.80 per share

Vitrolife AB (Publ) Proposes Dividend

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Vitrolife AB (Publ) Proposes Dividend

Third quarter 2021 earnings released: EPS kr0.89 (vs kr0.81 in 3Q 2020)

Second quarter 2021 earnings released: EPS kr0.79 (vs kr0.11 in 2Q 2020)

Vitrolife AB (publ) Approves Dividend for the Financial Year 2020

First quarter 2021 earnings released: EPS kr1.09 (vs kr0.73 in 1Q 2020)

Upcoming dividend of kr0.80 per share

Full year 2020 earnings released: EPS kr2.64 (vs kr3.53 in FY 2019)

Full year 2020 earnings released: EPS kr2.64 (vs kr3.53 in FY 2019)

Revenue misses expectations

New 90-day high: kr237

Vitrolife AB (publ) to Report Fiscal Year 2020 Results on Feb 10, 2021

New 90-day low: kr209

Revenue beats expectations

Third quarter 2020 earnings released: EPS kr0.81

Vitrolife AB (publ) to Report Fiscal Year 2020 Results on Mar 30, 2021

Vitrolife AB (publ) to Report Q1, 2021 Results on Apr 22, 2021

Vitrolife AB (Publ) Announces Appointment of Election Committee

New 90-day high - kr246